RHEUMATOLOGY_INTIME_LTD - Accounts


Company Registration No. SC494394 (Scotland)
RHEUMATOLOGY INTIME LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2019
PAGES FOR FILING WITH REGISTRAR
RHEUMATOLOGY INTIME LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
RHEUMATOLOGY INTIME LTD
BALANCE SHEET
AS AT
31 JANUARY 2019
31 January 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,641
3,521
Current assets
Debtors
13,878
8,727
Cash at bank and in hand
44,165
26,164
58,043
34,891
Creditors: amounts falling due within one year
(15,013)
(10,010)
Net current assets
43,030
24,881
Total assets less current liabilities
45,671
28,402
Capital and reserves
Called up share capital
4
100
100
Profit and loss reserves
45,571
28,302
Total equity
45,671
28,402

In accordance with section 444 of the Companies Act 2006 all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (S.I. 2008/409)(b).

For the financial year ended 31 January 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 20 August 2019 and are signed on its behalf by:
Mrs Hazel McKay
Mr Neil McKay
Director
Director
Company Registration No. SC494394
RHEUMATOLOGY INTIME LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2019
- 2 -
1
Accounting policies
Company information

Rheumatology Intime Ltd is a private company limited by shares incorporated in Scotland. The registered office is 34 Craigleith View, Edinburgh, Scotland, EH4 3JY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover comprises revenue recognised by the company in respect of consultancy services supplied during the period.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
25% reducing balance
1.4
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

RHEUMATOLOGY INTIME LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2019
1
Accounting policies
(Continued)
- 3 -
1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.9
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 4 (2018 - 4).

3
Tangible fixed assets
Computer equipment
£
Cost
At 1 February 2018 and 31 January 2019
5,905
Depreciation and impairment
At 1 February 2018
2,384
Depreciation charged in the year
880
At 31 January 2019
3,264
Carrying amount
At 31 January 2019
2,641
At 31 January 2018
3,521
RHEUMATOLOGY INTIME LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2019
- 4 -
4
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
70 Ordinary A Shares of £1 each
70
70
30 Ordinary B Shares of £1 each
30
30
100
100
2019-01-312018-02-01false20 August 2019CCH SoftwareCCH Accounts Production 2019.301No description of principal activityMrs Hazel McKayMr Neil McKaySC4943942018-02-012019-01-31SC4943942019-01-31SC4943942018-01-31SC494394core:ComputerEquipment2019-01-31SC494394core:ComputerEquipment2018-01-31SC494394core:CurrentFinancialInstruments2019-01-31SC494394core:CurrentFinancialInstruments2018-01-31SC494394core:ShareCapital2019-01-31SC494394core:ShareCapital2018-01-31SC494394core:RetainedEarningsAccumulatedLosses2019-01-31SC494394core:RetainedEarningsAccumulatedLosses2018-01-31SC494394core:ShareCapitalOrdinaryShares2019-01-31SC494394core:ShareCapitalOrdinaryShares2018-01-31SC494394bus:Director12018-02-012019-01-31SC494394bus:Director22018-02-012019-01-31SC494394core:ComputerEquipment2018-02-012019-01-31SC494394core:ComputerEquipment2018-01-31SC494394bus:OrdinaryShareClass12018-02-012019-01-31SC494394bus:OrdinaryShareClass22018-02-012019-01-31SC494394bus:OrdinaryShareClass12019-01-31SC494394bus:OrdinaryShareClass22019-01-31SC494394bus:PrivateLimitedCompanyLtd2018-02-012019-01-31SC494394bus:SmallCompaniesRegimeForAccounts2018-02-012019-01-31SC494394bus:FRS1022018-02-012019-01-31SC494394bus:AuditExemptWithAccountantsReport2018-02-012019-01-31SC494394bus:FullAccounts2018-02-012019-01-31xbrli:purexbrli:sharesiso4217:GBP